The agency said Pfizer ignored hundreds of complaints that the device failed to operate in life-threatening emergencies, including incidents when patients died
The agency reported actions against a biotech company and two large stem cell clinics over unapproved treatments, a move it said was necessary to make way for speedier approval of legitimate therapies.
The Senate capped a difficult seven months on Thursday by approving financing for the F.D.A. and expanding access to experimental treatments for people with terminal illnesses.
By SHEILA KAPLAN July 28, 2017 Electronic-cigarette makers won a major reprieve on Friday when the Food and Drug Administration delayed regulations that could have removed many of their products from the market and opened the door to endorsing e-cigarettes...